Skip to main content
TipRanks
Go Ultimate75% OFF

Biofrontera (0DOL) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Biofrontera has a market cap or net worth of EUR 16.83M. The enterprise value is EUR 11.99M.

Market Cap
EUR 16.83M
Enterprise Value
EUR 11.99M

Share Statistics

Biofrontera has 6,076,862 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
6,076,862
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Biofrontera’s return on equity (ROE) is -0.27 and return on invested capital (ROIC) is -6.58%.

Return on Equity (ROE)
-0.27
Return on Assets (ROA)
-0.19
Return on Invested Capital (ROIC)
-6.58%
Return on Capital Employed (ROCE)
-0.07
Revenue Per Employee
212.73K
Profits Per Employee
-63.95K
Employee Count
62
Asset Turnover
0.64
Inventory Turnover
0.61

Valuation Ratios

The current PE Ratio of Biofrontera is -1.48. Biofrontera’s PEG ratio is -0.01.

PE Ratio
-1.48
PS Ratio
0.18
PB Ratio
-37.12
Price to FCF
-1.58
Price to Operating Cash Flow
-1.63
PEG Ratio
-0.01

Income Statement

In the last 12 months, Biofrontera had revenue of 13.19M and earned -3.96M in profits. Earnings per share was -0.65.

Revenue
13.19M
Gross Profit
10.91M
Operating Income
-1.02M
Pretax Income
-1.22M
Net Income
-3.96M
EBITDA
-560.00K
Earnings Per Share (EPS)
-0.65

Cash Flow

In the last 12 months, operating cash flow was 772.00K and capital expenditures 0, giving a free cash flow of 772.00K billion.

Operating Cash Flow
772.00K
Free Cash Flow
772.00K
Free Cash Flow per Share
-0.36

Dividends & Yields

Biofrontera pays an annual dividend of EUR 0.29, resulting in a dividend yield of ―

Dividend Per Share
EUR 0.29
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-65.20%
Earnings Yield
-70.11%

Stock Price Statistics

Beta
-0.50
52-Week Price Change
-80.56%
50-Day Moving Average
2.98
200-Day Moving Average
2.92
Relative Strength Index (RSI)
43.75
Average Volume (3m)
273

Important Dates

Biofrontera upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date
Jun 03, 2026
Next Earnings Date
―
Ex-Dividend Date
Mar 15, 2022

Financial Position

Biofrontera as a current ratio of 2.43, with Debt / Equity ratio of 4.20%

Current Ratio
2.43
Quick Ratio
1.77
Debt to Market Cap
0.04
Net Debt to EBITDA
5.32
Interest Coverage Ratio
-73.21

Taxes

In the past 12 months, Biofrontera has paid 5.72M in taxes.

Income Tax
5.72M
Effective Tax Rate
-4.68

Enterprise Valuation

Biofrontera EV to EBITDA ratio is -2.40, with an EV/FCF ratio of -2.31.

EV to Sales
0.27
EV to EBITDA
-2.40
EV to Free Cash Flow
-2.31
EV to Operating Cash Flow
-2.32

Balance Sheet

Biofrontera has EUR 3.08M in cash and marketable securities with EUR 1.15M in debt, giving a net cash position of EUR 1.93M billion.

Cash & Marketable Securities
EUR 3.08M
Total Debt
EUR 1.15M
Net Cash
EUR 1.93M
Net Cash Per Share
EUR 0.32
Tangible Book Value Per Share
EUR 0.30

Margins

Gross margin is 84.60%, with operating margin of -9.50%, and net profit margin of -12.72%.

Gross Margin
84.60%
Operating Margin
-9.50%
Pretax Margin
-12.67%
Net Profit Margin
-12.72%
EBITDA Margin
-11.06%
EBIT Margin
-12.44%

Scores

Smart Score
3
AI Score
―